Cheiron Scores $8M Seed Round

Cheiron raised an $8 million seed round to expand its drug-program operating system.

The financing was led by Menlo Ventures and backed by several prominent industry veterans.

The investor lineup signals strong support from both biotech and tech leaders for Cheiron’s platform.